Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial

BACKGROUND: This study aimed to evaluate whether selecting mirtazapine as the first choice for current depressive episode instead of selective serotonin reuptake inhibitors (SSRIs) reduces benzodiazepine use in patients with major depressive disorder (MDD). We concurrently examined the relationship...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Gen Psychiatry
Main Authors: Hashimoto, Tasuku, Shiina, Akihiro, Hasegawa, Tadashi, Kimura, Hiroshi, Oda, Yasunori, Niitsu, Tomihisa, Ishikawa, Masatomo, Tachibana, Masumi, Muneoka, Katsumasa, Matsuki, Satoshi, Nakazato, Michiko, Iyo, Masaomi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Primary Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070072/
https://ncbi.nlm.nih.gov/pubmed/27777607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12991-016-0115-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares